|
RIC8B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.840600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.803600E-01 |
| Normal-vs-Stage2 |
1.274590E-01 |
| Normal-vs-Stage3 |
1.44339999952336E-07 |
| Normal-vs-Stage4 |
4.57509999995942E-06 |
| Stage1-vs-Stage2 |
4.332600E-01 |
| Stage1-vs-Stage3 |
1.92543999999462E-05 |
| Stage1-vs-Stage4 |
7.212500E-04 |
| Stage2-vs-Stage3 |
5.424400E-02 |
| Stage2-vs-Stage4 |
6.806400E-02 |
| Stage3-vs-Stage4 |
9.165400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.764500E-04 |
| Normal-vs-AfricanAmerican |
5.772200E-04 |
| Normal-vs-Asian |
9.075000E-01 |
| Caucasian-vs-AfricanAmerican |
1.234390E-01 |
| Caucasian-vs-Asian |
3.300400E-01 |
| AfricanAmerican-vs-Asian |
1.232040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00990000000156E-05 |
| Normal-vs-Female |
5.935800E-02 |
| Male-vs-Female |
5.361800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.400460E-02 |
| Normal-vs-Age(41-60Yrs) |
1.888160E-02 |
| Normal-vs-Age(61-80Yrs) |
1.789900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.209030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.324010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.963000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.211400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.721240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.586600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.579800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.357790E-01 |
| Normal-vs-Grade 2 |
4.289400E-01 |
| Normal-vs-Grade 3 |
1.50230000000029E-05 |
| Normal-vs-Grade 4 |
2.76410005994876E-10 |
| Grade 1-vs-Grade 2 |
2.134000E-01 |
| Grade 1-vs-Grade 3 |
3.643200E-03 |
| Grade 1-vs-Grade 4 |
1.91213999999329E-05 |
| Grade 2-vs-Grade 3 |
2.012800E-04 |
| Grade 2-vs-Grade 4 |
4.78679995641329E-09 |
| Grade 3-vs-Grade 4 |
2.423100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.498000E-01 |
| Normal-vs-ccB subtype |
1.14530000039359E-07 |
| ccA subtype-vs-ccB subtype |
1.39870004467468E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.857910E-03 |
| Normal-vs-N1 |
3.721700E-02 |
| N0-vs-N1 |
2.862800E-01 |
|
|
